Literature DB >> 22078220

Analysis of echocardiograms in a large heterogeneous cohort of patients with friedreich ataxia.

Sean R Regner1, Sarah J Lagedrost, Ted Plappert, Erin K Paulsen, Lisa S Friedman, Madeline L Snyder, Susan L Perlman, Katherine D Mathews, George R Wilmot, Kimberly A Schadt, Martin St John Sutton, David R Lynch.   

Abstract

Although Friedreich ataxia (FA) is associated with cardiomyopathy, the severity and evolution of cardiac disease is poorly understood. To identify factors predicting cardiomyopathy in FA, we assessed echocardiograms from a large heterogenous cohort and their relation to disease traits. The most recent echocardiograms from 173 subjects with FA were analyzed in a core laboratory to determine their relation to disease duration, subject age, age of onset, functional disability score, and GAA repeat length. Mean age of the cohort was 19.7 years, mean age of disease onset was 10.6 years, and mean shorter GAA length was 681 repeats. Echocardiograms collectively illustrated systolic dysfunction, diastolic dysfunction, and hypertrophy. Measurements of hypertrophy correlated moderately with each other (r = 0.39 to 0.79) but not with measurements of diastolic dysfunction (r <0.35). Diastolic measurements correlated poorly with each other, although 26% of the cohort had multiple diastolic abnormalities. The most common diastolic dysfunction classification was pseudonormalization. Classification of diastolic dysfunction was predicted by GAA repeat length but not by age or gender. Ejection fraction was below normal in 20% of the cohort. In linear regression analysis, increasing age predicted decreasing ejection fraction. Functional disability score, a measurement of neurologic ability, did not predict any echocardiographic measurements. In conclusion, hypertrophy and diastolic and systolic dysfunctions occur in FA and are substantially independent; diastolic dysfunction is the most common abnormality with most patients having an assigned diastolic dysfunction class of pseudonormalization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22078220     DOI: 10.1016/j.amjcard.2011.09.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length.

Authors:  Yogesh K Chutake; Christina Lam; Whitney N Costello; Michael Anderson; Sanjay I Bidichandani
Journal:  Ann Neurol       Date:  2014-08-30       Impact factor: 10.422

Review 2.  [Heart involvement in Friedreich's ataxia].

Authors:  F Weidemann; F Scholz; C Florescu; D Liu; K Hu; S Herrmann; G Ertl; S Störk
Journal:  Herz       Date:  2014-05-23       Impact factor: 1.443

Review 3.  Genetic Infiltrative Cardiomyopathies.

Authors:  Mary E Sweet; Luisa Mestroni; Matthew R G Taylor
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

4.  A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model.

Authors:  Piyush M Vyas; Wendy J Tomamichel; P Melanie Pride; Clifford M Babbey; Qiujuan Wang; Jennifer Mercier; Elizabeth M Martin; R Mark Payne
Journal:  Hum Mol Genet       Date:  2011-11-23       Impact factor: 6.150

Review 5.  Cardiomyopathy in Friedreich ataxia: clinical findings and research.

Authors:  R Mark Payne; Gregory R Wagner
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

Review 6.  Clinical features of Friedreich ataxia.

Authors:  Martin B Delatycki; Louise A Corben
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

7.  Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants.

Authors:  Sean R Regner; Nicholas S Wilcox; Lisa S Friedman; Lauren A Seyer; Kim A Schadt; Karlla W Brigatti; Susan Perlman; Martin Delatycki; George R Wilmot; Christopher M Gomez; Khalaf O Bushara; Katherine D Mathews; S H Subramony; Tetsuo Ashizawa; Bernard Ravina; Alicia Brocht; Jennifer M Farmer; David R Lynch
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

8.  Cross-sectional analysis of electrocardiograms in a large heterogeneous cohort of Friedreich ataxia subjects.

Authors:  Kimberly A Schadt; Lisa S Friedman; Sean R Regner; George E Mark; David R Lynch; Kimberly Y Lin
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

Review 9.  Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain.

Authors:  Hidekazu Tanaka
Journal:  J Echocardiogr       Date:  2021-01-18

Review 10.  Friedreich's ataxia: clinical features, pathogenesis and management.

Authors:  A Cook; P Giunti
Journal:  Br Med Bull       Date:  2017-12-01       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.